Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IGK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CLIC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
APOOL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANP32A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIFAB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM56 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2E2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPNT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF4G2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERINC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LCORL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIP2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTMR6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WTAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP57 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENPEP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS13A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on